ID: ALA4800628

Max Phase: Preclinical

Molecular Formula: C15H18ClFN6O3

Molecular Weight: 384.80

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Nc1nc(Cl)nc2c1ncn2[C@H]1[C@H](O)[C@H](O)[C@]2(C(=O)NCCCF)C[C@H]12

Standard InChI:  InChI=1S/C15H18ClFN6O3/c16-14-21-11(18)7-12(22-14)23(5-20-7)8-6-4-15(6,10(25)9(8)24)13(26)19-3-1-2-17/h5-6,8-10,24-25H,1-4H2,(H,19,26)(H2,18,21,22)/t6-,8-,9+,10+,15+/m1/s1

Standard InChI Key:  XTFAHNFBCMTXMV-RFXZSQAESA-N

Associated Targets(Human)

Endoplasmin 514 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Heat shock protein HSP 90-alpha 4115 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 384.80Molecular Weight (Monoisotopic): 384.1113AlogP: -0.18#Rotatable Bonds: 5
Polar Surface Area: 139.18Molecular Species: NEUTRALHBA: 8HBD: 4
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.12CX Basic pKa: 2.38CX LogP: -1.12CX LogD: -1.12
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.41Np Likeness Score: 0.08

References

1. Tosh DK,Brackett CM,Jung YH,Gao ZG,Banerjee M,Blagg BSJ,Jacobson KA.  (2021)  Biological Evaluation of 5'-(N-Ethylcarboxamido)adenosine Analogues as Grp94-Selective Inhibitors.,  12  (3): [PMID:33738064] [10.1021/acsmedchemlett.0c00509]

Source